Healthcare -
Biotechnology - NASDAQ - US
$ 3.9
-3.23 %
$ 272 M
Market Cap
-0.74
P/E
PHAT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PHAT - Phathom Pharmaceuticals, Inc.
183 M
LAST VALUE
23.39%
2 YEAR CAGR
-9.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR